#INDSWIFT - Twitter Hashtag

about 16 hours ago

Pharmacy chalana hi kaafi hai, paperwork mein time kyun lagana? Less paperwork. Smarter operations. Better business growth! Download SwiftPlus+ Partner today. #SwiftPlusPlus #PharmacyManagement #SmartPharmacy #DigitalHealthcare #IndSwift

indswiftlabs's tweet photo. Pharmacy chalana hi kaafi hai, paperwork mein time kyun lagana?

Less paperwork. Smarter operations. Better business growth!

Download SwiftPlus+ Partner today.

#SwiftPlusPlus #PharmacyManagement #SmartPharmacy #DigitalHealthcare #IndSwift https://t.co/rrizrgepGv

0

19

Ind-Swift Labs Ltd. @indswiftlabs

4 days ago

I-Learn के ज़रिए वन-टू-वन कोचिंग, और इंटरनल जॉब पोस्टिंग, जहाँ बड़ी भूमिकाएँ पहले हमारे अपने लोगों के लिए। 🚀कहीं और से पहले, यहीं आगे बढ़ें। अगला अध्याय 7: सम्मान और सुनवाई। जुड़े रहिए!#SwiftHCM #LifeAtIndSwift #TheStoryOfYou #IndSwift #उद्देश्य #आपकीकहानी

0

72

Ind-Swift Labs Ltd. @indswiftlabs

4 days ago

and internal job postings that open bigger roles to our own people first. 🚀Grow here, before you grow anywhere. Next up: Chapter 7, Rewarded & heard. Stay tuned!#SwiftHCM #LifeAtIndSwift #TheStoryOfYou #IndSwift #Udeshya #CareerGrowth #LearningAndDevelopment #GrowWithUs

0

47

CA Sai Varun

@SaiVaru48492050

9 days ago

Added Ind-Swift today at ₹365 CMP. Investment Horizon: 1–2 years Disclaimer: This is just my personal investment update, not a buy recommendation. I may buy or sell shares at any time, including before or after this post is published. #Indswift #CDMO #Pharma

CA Sai Varun

@SaiVaru48492050

10 days ago

IND-SWIFT LABORATORIES – FY27 & FY28 Growth Outlook As per management commentary: ✅ FY27: Revenue growth expected to exceed 50% YoY. ✅ FY28: Management targeting revenue of ₹1,100 Cr or more. ✅ Medium-term: Revenue CAGR guidance of 20–25%. ✅ EBITDA Margins: Management expects further expansion of 200–300 bps. Q2 FY27 Performance: - Revenue: ₹234.89 Cr (+50.15% YoY) - PAT: ₹31.03 Cr (3.54x YoY) - EBITDA Margin: 18.02% Growth drivers include CDMO partnerships, export expansion and a shift towards higher-margin formulations. Not a buy/sell recommendation. Personal view. #Indswift #CDMO #Pharma

SaiVaru48492050's tweet photo. IND-SWIFT LABORATORIES – FY27 & FY28 Growth Outlook

As per management commentary:

✅ FY27: Revenue growth expected to exceed 50% YoY.

✅ FY28: Management targeting revenue of ₹1,100 Cr or more.

✅ Medium-term: Revenue CAGR guidance of 20–25%.

✅ EBITDA Margins: Management expects further expansion of 200–300 bps.

Q2 FY27 Performance:

- Revenue: ₹234.89 Cr (+50.15% YoY)
- PAT: ₹31.03 Cr (3.54x YoY)
- EBITDA Margin: 18.02%

Growth drivers include CDMO partnerships, export expansion and a shift towards higher-margin formulations.

Not a buy/sell recommendation. Personal view.

#Indswift #CDMO #Pharma

2

15

1

6

4K

0

16

0

9

2K

Srinivasa D @DSR26S

15 days ago

Preopening Status : #LaurusLab up 2.5% #IndSwift up 6% #RBA - Turn around story #BharatParenter #MTAR 5% UC #KRN 5% LC #milkymist 3% #greenply #EquitasSFB #WheelsIndia #nilkamal #parasdef #pinelabs #privispeciality #KRISHNADEF 20% UC #DeepakNitrite 3%

Srinivasa D @DSR26S

16 days ago

#Q2FY27 #Results that are worth analyzing today 29/10. #LaurusLab #IndSwift #RBA - Turn around story #BharatParenter #MTAR #KRN #milkymist #greenply #EquitasSFB #WheelsIndia #nilkamal #parasdef #pinelabs #privispeciality #study #StocksToWatch #vismaya

0

14

0

5

3K

0

7

1

4

1K

Attentive investor

@stockmarket8058

16 days ago

11 . Ind Swift Labs #indswift

1

3

1

2

654

Srinivasa D @DSR26S

16 days ago

#Q2FY27 #Results that are worth analyzing today 29/10. #LaurusLab #IndSwift #RBA - Turn around story #BharatParenter #MTAR #KRN #milkymist #greenply #EquitasSFB #WheelsIndia #nilkamal #parasdef #pinelabs #privispeciality #study #StocksToWatch #vismaya

0

14

0

5

3K

The Cloaked Gaze 👀

@gaze_observer

16 days ago

Ind-Swift Laboratories — Q2FY27 Results 🔔 #Q2Results #Q2FY27 #Indswift Revenue ₹240.46 Cr vs ₹158.64 Cr (+51.58% YoY┃+25.60% QoQ) EBITDA ₹45.46 Cr vs ₹7.47 Cr (+508.49% YoY┃+35.98% QoQ) EBITDA Margin 18.91% vs 4.71% YoY & 17.46% QoQ PBT ₹43.38 Cr vs ₹10.34 Cr (+319.39% YoY┃+33.22% QoQ) PAT Before Share of JV/Associates ₹34.15 Cr vs ₹8.04 Cr (+324.60% YoY┃+38.99% QoQ) PAT ₹34.22 Cr vs ₹7.99 Cr (+328.30% YoY┃+38.64% QoQ) Other Income ₹7.60 Cr vs ₹11.86 Cr YoY & ₹7.65 Cr QoQ

gaze_observer's tweet photo. Ind-Swift Laboratories — Q2FY27 Results 🔔
#Q2Results #Q2FY27 #Indswift

Revenue ₹240.46 Cr vs ₹158.64 Cr
(+51.58% YoY┃+25.60% QoQ)

EBITDA ₹45.46 Cr vs ₹7.47 Cr
(+508.49% YoY┃+35.98% QoQ)

EBITDA Margin 18.91% vs 4.71% YoY & 17.46% QoQ

PBT ₹43.38 Cr vs ₹10.34 Cr
(+319.39% YoY┃+33.22% QoQ)

PAT Before Share of JV/Associates ₹34.15 Cr vs ₹8.04 Cr
(+324.60% YoY┃+38.99% QoQ)

PAT ₹34.22 Cr vs ₹7.99 Cr
(+328.30% YoY┃+38.64% QoQ)

Other Income ₹7.60 Cr vs ₹11.86 Cr YoY & ₹7.65 Cr QoQ

3

29

4

6

5K

Swing Trading School @school_swi61802

18 days ago

Focus only on #Pharmaceuticals : 2 stocks in PF 1. #SYMBIOTEC (Yesterday's position) 2. #MOREPEN (Bought Today) Some cash left. in watch - #Aartipharmalab & #INDswift (results awaited)

0

4

0

2

625

Investment2Success 🇮🇳 @Investment2Su

20 days ago

Top 10 big winners of 2026 :- 👇👇 #SterliteTechnologies :- 700% Return #BlissGVSPharma :- 280%+ #IndSwift :- 270%+ #HFCL :- 250%+ #SkyGold :- 210%+ #Omnitech :- 210% #MorepenLaboratories :- 200%+ #Cupid :- 330%+ #Diamondpower :- 200%+ #Investment #multibagger

0

4

1

3

319

we will grow together

@Valivetimrl

about 2 months ago

#IndSWift Labs even after a move from 150 to 370 , why Ind Swift labs was a steal at 320 which it fell in recent microcap volatility . Company guiding for 50% growth and margins movement from 17% to 20 % and roughly 22% in 2 years . Fy28 1000-1100 cr revenue and 220 -240 cr ebidta is really possible . For a debt free balance sheet 25 times EV/Ebidta is very much possilbe and gives roughly 6000 cr mcap . List of customers and great work happening on registrations front

Valivetimrl's tweet photo. #IndSWift Labs even after a move from 150 to 370 , why Ind Swift labs was a steal at 320 which it fell in recent microcap volatility . Company guiding for 50% growth and margins movement from 17% to 20 % and roughly 22% in 2 years . Fy28 1000-1100 cr revenue and 220 -240 cr ebidta is really possible . For a debt free balance sheet 25 times EV/Ebidta is very much possilbe and gives roughly 6000 cr mcap . List of customers and great work happening on registrations front

2

45

7

33

6K

My First Stock

@myfirststock99

2 months ago

When I say study yourself #Indswift hits 5x

5

110

1

20

17K

Maulik(Mikka)🇮🇳🔆

@MaulikMikka

3 months ago

Successfully Missed all trades #INOXINDIA #IDEA #INDSWIFT

0

3

0

449

Dream 2 Wealth🚀 @Dream2Wealth

3 months ago

Stock - #IndSwift Stock shared on 18/06/26 at 165 Almost 2 months and stock gave 120% return 🔥🔥🧘🚀🚀 Ho gya paisa double🥸 , Just believe in you and believe in manifestation

Dream2Wealth's tweet photo. Stock - #IndSwift

Stock shared on 18/06/26 at 165
Almost 2 months and stock gave 120% return 🔥🔥🧘🚀🚀

Ho gya paisa double🥸 , Just believe in you and believe in manifestation https://t.co/Qw8moIkfcF

Dream 2 Wealth🚀 @Dream2Wealth

5 months ago

Entry trigger guys at 165 #Indswift

0

2

1

5K

1

4

0

1

778

Abhishek pandey 🇮🇳💵📈🔰💎🐂

@Abhishe79459720

3 months ago

140 to 350 my all tgt hit 🩷🩷 #indswift

Abhishek pandey 🇮🇳💵📈🔰💎🐂

@Abhishe79459720

6 months ago

💸💸💸💸💸💸 बलिया रिकार्ड बोलदे ❤️❤️💸💸💸💸💸💥💥💥#Indswift

0

22

0

4K

1

19

1

2K

Sudheer

@SudheerVSC

3 months ago

#INDswift laboratories ADD this to your chart library: Perfect Stage 2. A+ setup for me. Breaking ATH. Didn’t HOLD it long, because I lacked conviction. You’ll miss many great setups in your trading journey. That’s part of the game.

SudheerVSC's tweet photo. #INDswift laboratories
ADD this to your chart library:

Perfect Stage 2.
A+ setup for me.
Breaking ATH.

Didn’t HOLD it long, because I lacked conviction.

You’ll miss many great setups in your trading journey. That’s part of the game. https://t.co/VIsRzpuZdI

0

4

0

270

Abhishek pandey 🇮🇳💵📈🔰💎🐂

@Abhishe79459720

3 months ago

Indswift 8% up #indswift

0

9

0

2K

Raghav Chaudhary

@MrRChaudhary

3 months ago · Mumbai

#Indswift - Fy26 sales 650crs, guides for CDMO sales 650crs by Fy29. *18% EBITDA Sustainable Ebitda Margins & could go upto 21-22%* 400+ dossiers to be filed

0

49

3

20

11K